ARCHIVES

Key Cancer Legislation Remains Unfinished as Congress Departs for Election.

This article is from The Cancer Letter archive.

Vol. 32 No. 35 | October 6, 2006

Download PDF Visit The Full Archive

Related Articles

NCI To Require Reports On Adverse Drug Reactions From Trials

June 10, 1994

Spending Measures Include Provisions On Ethics For NIH Extramural Scientists.

July 11, 2008

Guideline Revisions or Outstanding Investigator Grant Still Controversial

December 9, 1983

Rep. Wyden Questions NCI Motive For Choosing Not To Pursue RU 486

September 4, 1992

DCCP Board Approves Concepts Of $2.6 Million In New Competing Projects, $1.2 Million In Recompetitions

September 25, 1981

NIH Review Division Considering Proposal For Clinical Oncology Study Section

October 10, 1997